Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis
- 15 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (12) , 2995-3001
- https://doi.org/10.1161/01.cir.91.12.2995
Abstract
Background Vascular interventions that maximize initial lumen diameter provoke extensive neointimal hyperplasia but minimize its effects, causing long-term lumen size to be greater. Nevertheless, interventions such as endovascular stents, which increase lumen size above that achieved with balloon angioplasty, are subject to frequent thrombosis and restenosis. It has been unclear whether the response to stent-induced injury is determined solely by the degree of stent-induced arterial expansion or whether the geometric configuration of the stent or the material left in contact with the vessel wall also contribute. Methods and Results We examined the vascular response to steel stents deployed in denuded rabbit iliac arteries for 14 days. In one set of experiments, the effects of stent configuration were examined, holding diameter, mass, surface area, and stent surface material constant. In another set, stent surface material was changed, with mass, configuration, and diameter unaltered. Changing stent configuration to reduce strut-strut intersections by 29% without affecting mass or surface area reduced vascular injury by 42%, thrombosis by 69%, and neointimal hyperplasia by 38%. Monocyte adhesion to stented arteries correlated linearly with vascular trauma and neointimal hyperplasia ( r =.96, P <.01 for each). When the stainless steel surface was coated with an inert polymer material, vascular injury and neointimal hyperplasia were unchanged, but thrombosis was eliminated. Conclusions Surface material and geometric configuration of stents may be more important than postplacement diameter in determining neointimal hyperplasia and thrombosis. Alterations in configuration affect vascular injury and neointimal hyperplasia, while surface material plays a greater role in thrombosis. Monocytes may be important modulators of stent-induced intimal thickening. Clinical confirmation of these findings may alter coronary stent deployment techniques and future stent designs.Keywords
This publication has 31 references indexed in Scilit:
- Coronary restenosis: Evaluation of a restenosis injury index in a swine modelAmerican Heart Journal, 1993
- Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcomeJournal of the American College of Cardiology, 1993
- Coronary aneurysms after stent placement: A suggestion of altered vessel wall healing in the presence of anti-inflammatory agentsJournal of the American College of Cardiology, 1991
- Clinical and angiographic results of balloon-expandable intracoronary stents in right coronary artery stenosesJournal of the American College of Cardiology, 1990
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985